Global Anti-CD20 Monoclonal Antibodies (mABs) Market 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	161 Pages	TechNavio	October, 2023	INF18285543

Best Price Guarantee
Price	from $2,500
Length	161 Pages
Publisher	TechNavio
Published Date	October, 2023
SKU	INF18285543

Global Anti-CD20 Monoclonal Antibodies (mABs) Market 2024-2028

The Anti-CD20 monoclonal antibodies (mABs) market is forecasted to grow by USD 11425.15 mn during 2023-2028, accelerating at a CAGR of 10.31% during the forecast period. The report on the Anti-CD20 monoclonal antibodies (mABs) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increased use of combination therapies, high target affinity and specificity of Anti-CD20 mABs, and strong pipeline and recent approvals.

Technavio's Anti-CD20 monoclonal antibodies (mABs) market is segmented as below:

By Product

Oncology
Neurology
Immunology

By Type

First generation Anti-CD20 monoclonal antibody
Second generation Anti-CD20 monoclonal antibody
Third generation Anti-CD20 monoclonal antibody

By Geography

North America
Europe
Asia
Rest of World (ROW)

This study identifies the increasing awareness about therapeutic areas as one of the prime reasons driving the Anti-CD20 monoclonal antibodies (mABs) market growth during the next few years. Also, the presence of reimbursement and patient assistance programs and the development of cd20 bispecific antibodies will lead to sizable demand in the market.

The report on the Anti-CD20 monoclonal antibodies (mABs) market covers the following areas:

Anti-CD20 monoclonal antibodies (mABs) market sizing
Anti-CD20 monoclonal antibodies (mABs) market forecast
Anti-CD20 monoclonal antibodies (mABs) market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading Anti-CD20 monoclonal antibodies (mABs) market vendors that include Acrotech Biopharma Inc., Amgen Inc., AstraZeneca Plc, Celltrion Healthcare Co. Ltd., F. Hoffmann La Roche Ltd., Fosun International Ltd., Genmab AS, IGM Biosciences Inc., JSC BIOCAD, LFB SA, Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals Inc., Spectrum Pharmaceuticals Inc., TG Therapeutics Inc., United BioPharma Inc., and ZHEJIANG HISUN PHARMACEUTICAL Co. Ltd.. Also, the Anti-CD20 monoclonal antibodies (mABs) market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Executive Summary
- Market overview
  - Table Executive Summary - Chart on Market Overview
  - Table Executive Summary - Data Table on Market Overview
  - Table Executive Summary - Chart on Global Market Characteristics
  - Table Executive Summary - Chart on Market by Geography
  - Table Executive Summary - Chart on Market Segmentation by Product
  - Table Executive Summary - Chart on Market Segmentation by Type
  - Table Executive Summary - Chart on Incremental Growth
  - Table Executive Summary - Data Table on Incremental Growth
  - Table Executive Summary - Chart on Vendor Market Positioning
Market Landscape
- Market ecosystem
  - Table Parent market
  - Table Market Characteristics
Market Sizing
- Market definition
  - Table Offerings of vendors included in the market definition
- Market segment analysis
  - Table Market segments
- Market size 2023
- Market outlook: Forecast for 2023-2028
  - Table Chart on Global - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on Global - Market size and forecast 2023-2028 ($ million)
  - Table Chart on Global Market: Year-over-year growth 2023-2028 (%)
  - Table Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Historic Market Size
- Global anti-CD20 monoclonal antibodies (mABs) market 2018 - 2022
  - Table Historic Market Size - Data Table on global anti-CD20 monoclonal antibodies (mABs) market 2018 - 2022 ($ million)
- Product Segment Analysis 2018 - 2022
  - Table Historic Market Size - Product Segment 2018 - 2022 ($ million)
- Type Segment Analysis 2018 - 2022
  - Table Historic Market Size - Type Segment 2018 - 2022 ($ million)
- Geography Segment Analysis 2018 - 2022
  - Table Historic Market Size - Geography Segment 2018 - 2022 ($ million)
- Country Segment Analysis 2018 - 2022
  - Table Historic Market Size - Country Segment 2018 - 2022 ($ million)
Five Forces Analysis
- Five forces summary
  - Table Five forces analysis - Comparison between 2023 and 2028
- Bargaining power of buyers
  - Table Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
- Bargaining power of suppliers
  - Table Bargaining power of suppliers - Impact of key factors in 2023 and 2028
- Threat of new entrants
  - Table Threat of new entrants - Impact of key factors in 2023 and 2028
- Threat of substitutes
  - Table Threat of substitutes - Impact of key factors in 2023 and 2028
- Threat of rivalry
  - Table Threat of rivalry - Impact of key factors in 2023 and 2028
- Market condition
  - Table Chart on Market condition - Five forces 2023 and 2028
Market Segmentation by Product
- Market segments
  - Table Chart on Product - Market share 2023-2028 (%)
  - Table Data Table on Product - Market share 2023-2028 (%)
- Comparison by Product
  - Table Chart on Comparison by Product
  - Table Data Table on Comparison by Product
- Oncology - Market size and forecast 2023-2028
  - Table Chart on Oncology - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on Oncology - Market size and forecast 2023-2028 ($ million)
  - Table Chart on Oncology - Year-over-year growth 2023-2028 (%)
  - Table Data Table on Oncology - Year-over-year growth 2023-2028 (%)
- Neurology - Market size and forecast 2023-2028
  - Table Chart on Neurology - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on Neurology - Market size and forecast 2023-2028 ($ million)
  - Table Chart on Neurology - Year-over-year growth 2023-2028 (%)
  - Table Data Table on Neurology - Year-over-year growth 2023-2028 (%)
- Immunology - Market size and forecast 2023-2028
  - Table Chart on Immunology - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on Immunology - Market size and forecast 2023-2028 ($ million)
  - Table Chart on Immunology - Year-over-year growth 2023-2028 (%)
  - Table Data Table on Immunology - Year-over-year growth 2023-2028 (%)
- Market opportunity by Product
  - Table Market opportunity by Product ($ million)
  - Table Data Table on Market opportunity by Product ($ million)
Market Segmentation by Type
- Market segments
  - Table Chart on Type - Market share 2023-2028 (%)
  - Table Data Table on Type - Market share 2023-2028 (%)
- Comparison by Type
  - Table Chart on Comparison by Type
  - Table Data Table on Comparison by Type
- First generation anti-CD20 monoclonal antibody - Market size and forecast 2023-2028
  - Table Chart on First generation anti-CD20 monoclonal antibody - Market size and forecast 2023- 2028 ($ million)
  - Table Data Table on First generation anti-CD20 monoclonal antibody - Market size and forecast 2023-2028 ($ million)
  - Table Chart on First generation anti-CD20 monoclonal antibody - Year-over-year growth 2023- 2028 (%)
  - Table Data Table on First generation anti-CD20 monoclonal antibody - Year-over-year growth 2023-2028 (%)
- Second generation anti-CD20 monoclonal antibody - Market size and forecast 2023-2028
  - Table Chart on Second generation anti-CD20 monoclonal antibody - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on Second generation anti-CD20 monoclonal antibody - Market size and forecast 2023-2028 ($ million)
  - Table Chart on Second generation anti-CD20 monoclonal antibody - Year-over-year growth 2023- 2028 (%)
  - Table Data Table on Second generation anti-CD20 monoclonal antibody - Year-over-year growth 2023-2028 (%)
- Third generation anti-CD20 monoclonal antibody - Market size and forecast 2023-2028
  - Table Chart on Third generation anti-CD20 monoclonal antibody - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on Third generation anti-CD20 monoclonal antibody - Market size and forecast 2023-2028 ($ million)
  - Table Chart on Third generation anti-CD20 monoclonal antibody - Year-over-year growth 2023- 2028 (%)
  - Table Data Table on Third generation anti-CD20 monoclonal antibody - Year-over-year growth 2023-2028 (%)
- Market opportunity by Type
  - Table Market opportunity by Type ($ million)
  - Table Data Table on Market opportunity by Type ($ million)
Customer Landscape
- Customer landscape overview
  - Table Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Geographic Landscape
- Geographic segmentation
  - Table Chart on Market share by geography 2023-2028 (%)
  - Table Data Table on Market share by geography 2023-2028 (%)
- Geographic comparison
  - Table Chart on Geographic comparison
  - Table Data Table on Geographic comparison
- North America - Market size and forecast 2023-2028
  - Table Chart on North America - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on North America - Market size and forecast 2023-2028 ($ million)
  - Table Chart on North America - Year-over-year growth 2023-2028 (%)
  - Table Data Table on North America - Year-over-year growth 2023-2028 (%)
- Europe - Market size and forecast 2023-2028
  - Table Chart on Europe - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  - Table Chart on Europe - Year-over-year growth 2023-2028 (%)
  - Table Data Table on Europe - Year-over-year growth 2023-2028 (%)
- Asia - Market size and forecast 2023-2028
  - Table Chart on Asia - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on Asia - Market size and forecast 2023-2028 ($ million)
  - Table Chart on Asia - Year-over-year growth 2023-2028 (%)
  - Table Data Table on Asia - Year-over-year growth 2023-2028 (%)
- Rest of World (ROW) - Market size and forecast 2023- 2028
  - Table Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  - Table Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  - Table Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- US - Market size and forecast 2023-2028
  - Table Chart on US - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on US - Market size and forecast 2023-2028 ($ million)
  - Table Chart on US - Year-over-year growth 2023-2028 (%)
  - Table Data Table on US - Year-over-year growth 2023-2028 (%)
- Canada - Market size and forecast 2023-2028
  - Table Chart on Canada - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on Canada - Market size and forecast 2023-2028 ($ million)
  - Table Chart on Canada - Year-over-year growth 2023-2028 (%)
  - Table Data Table on Canada - Year-over-year growth 2023-2028 (%)
- Germany - Market size and forecast 2023-2028
  - Table Chart on Germany - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on Germany - Market size and forecast 2023-2028 ($ million)
  - Table Chart on Germany - Year-over-year growth 2023-2028 (%)
  - Table Data Table on Germany - Year-over-year growth 2023-2028 (%)
- UK - Market size and forecast 2023-2028
  - Table Chart on UK - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on UK - Market size and forecast 2023-2028 ($ million)
  - Table Chart on UK - Year-over-year growth 2023-2028 (%)
  - Table Data Table on UK - Year-over-year growth 2023-2028 (%)
- China - Market size and forecast 2023-2028
  - Table Chart on China - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on China - Market size and forecast 2023-2028 ($ million)
  - Table Chart on China - Year-over-year growth 2023-2028 (%)
  - Table Data Table on China - Year-over-year growth 2023-2028 (%)
- Market opportunity by geography
  - Table Market opportunity by geography ($ million)
  - Table Data Tables on Market opportunity by geography ($ million)
Drivers, Challenges, and Trends
- Market drivers
  - Increased use of combination therapies
  - High target affinity and specificity of anti-CD20 mABs
  - Strong pipeline and recent approvals
- Market challenges
  - Adverse effects of anti-CD20 mABs
  - Complexity in development of anti-CD20 monoclonal antibodies
  - Emergence of alternative therapies
- Impact of drivers and challenges
  - Table Impact of drivers and challenges in 2023 and 2028
- Market trends
  - Increasing awareness about therapeutic areas
  - Presence of reimbursement and patient assistance programs
  - Development of CD20 bispecific antibodies
Vendor Landscape
- Overview
- Vendor landscape
  - Table Overview on Criticality of inputs and Factors of differentiation
- Landscape disruption
  - Table Overview on factors of disruption
- Industry risks
  - Table Impact of key risks on business
Vendor Analysis
- Vendors covered
  - Table Vendors covered
- Market positioning of vendors
  - Table Matrix on vendor position and classification
- Acrotech Biopharma Inc.
  - Table Acrotech Biopharma Inc. - Overview
  - Table Acrotech Biopharma Inc. - Product / Service
  - Table Acrotech Biopharma Inc. - Key offerings
- Amgen Inc.
  - Table Amgen Inc. - Overview
  - Table Amgen Inc. - Product / Service
  - Table Amgen Inc. - Key offerings
- AstraZeneca Plc
  - Table AstraZeneca Plc - Overview
  - Table AstraZeneca Plc - Product / Service
  - Table AstraZeneca Plc - Key news
  - Table AstraZeneca Plc - Key offerings
- Celltrion Healthcare Co. Ltd.
  - Table Celltrion Healthcare Co. Ltd. - Overview
  - Table Celltrion Healthcare Co. Ltd. - Product / Service
  - Table Celltrion Healthcare Co. Ltd. - Key offerings
- F. Hoffmann La Roche Ltd.
  - Table F. Hoffmann La Roche Ltd. - Overview
  - Table F. Hoffmann La Roche Ltd. - Business segments
  - Table F. Hoffmann La Roche Ltd. - Key news
  - Table F. Hoffmann La Roche Ltd. - Key offerings
  - Table F. Hoffmann La Roche Ltd. - Segment focus
- Fosun International Ltd.
  - Table Fosun International Ltd. - Overview
  - Table Fosun International Ltd. - Product / Service
  - Table Fosun International Ltd. - Key offerings
- Genmab AS
  - Table Genmab AS - Overview
  - Table Genmab AS - Product / Service
  - Table Genmab AS - Key offerings
- IGM Biosciences Inc.
  - Table IGM Biosciences Inc. - Overview
  - Table IGM Biosciences Inc. - Product / Service
  - Table IGM Biosciences Inc. - Key offerings
- JSC BIOCAD
  - Table JSC BIOCAD - Overview
  - Table JSC BIOCAD - Product / Service
  - Table JSC BIOCAD - Key offerings
- LFB SA
  - Table LFB SA - Overview
  - Table LFB SA - Product / Service
  - Table LFB SA - Key offerings
- Novartis AG
  - Table Novartis AG - Overview
  - Table Novartis AG - Business segments
  - Table Novartis AG - Key offerings
  - Table Novartis AG - Segment focus
- Pfizer Inc.
  - Table Pfizer Inc. - Overview
  - Table Pfizer Inc. - Product / Service
  - Table Pfizer Inc. - Key news
  - Table Pfizer Inc. - Key offerings
- Regeneron Pharmaceuticals Inc.
  - Table Regeneron Pharmaceuticals Inc. - Overview
  - Table Regeneron Pharmaceuticals Inc. - Product / Service
  - Table Regeneron Pharmaceuticals Inc. - Key offerings
- Spectrum Pharmaceuticals Inc.
  - Table Spectrum Pharmaceuticals Inc. - Overview
  - Table Spectrum Pharmaceuticals Inc. - Product / Service
  - Table Spectrum Pharmaceuticals Inc. - Key offerings
- TG Therapeutics Inc.
  - Table TG Therapeutics Inc. - Overview
  - Table TG Therapeutics Inc. - Product / Service
  - Table TG Therapeutics Inc. - Key offerings
Appendix
- Scope of the report
  - Market definition
  - Objectives
  - Notes and caveats
- Inclusions and exclusions checklist
  - Table Inclusions checklist
  - Table Exclusions checklist
- Currency conversion rates for US$
  - Table Currency conversion rates for US$
- Research methodology
  - Table Research methodology
  - Table Validation techniques employed for market sizing
  - Table Information sources
- List of abbreviations
  - Table List of abbreviations